4//SEC Filing
CHALMERS DEREK T 4
Accession 0001209191-21-055304
CIK 0001346830other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:48 PM ET
Size
5.2 KB
Accession
0001209191-21-055304
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2021-09-07$15.47/sh−20,000$309,400→ 991,405 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.34 to $15.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001166287
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:48 PM ET
- Size
- 5.2 KB